- Germany
- /
- Healthcare Services
- /
- XTRA:FRE
Fresenius SE KGaA's (ETR:FRE) Soft Earnings Are Actually Better Than They Appear
The market for Fresenius SE & Co. KGaA's (ETR:FRE) shares didn't move much after it posted weak earnings recently. We think that the softer headline numbers might be getting counterbalanced by some positive underlying factors.
Check out our latest analysis for Fresenius SE KGaA
How Do Unusual Items Influence Profit?
To properly understand Fresenius SE KGaA's profit results, we need to consider the €406m expense attributed to unusual items. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual expenses don't come up again, we'd therefore expect Fresenius SE KGaA to produce a higher profit next year, all else being equal.
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
Our Take On Fresenius SE KGaA's Profit Performance
Unusual items (expenses) detracted from Fresenius SE KGaA's earnings over the last year, but we might see an improvement next year. Based on this observation, we consider it likely that Fresenius SE KGaA's statutory profit actually understates its earnings potential! On the other hand, its EPS actually shrunk in the last twelve months. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. If you'd like to know more about Fresenius SE KGaA as a business, it's important to be aware of any risks it's facing. When we did our research, we found 2 warning signs for Fresenius SE KGaA (1 makes us a bit uncomfortable!) that we believe deserve your full attention.
This note has only looked at a single factor that sheds light on the nature of Fresenius SE KGaA's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About XTRA:FRE
Fresenius SE KGaA
A health care company, provides products and services for chronically ill patients.
Undervalued with adequate balance sheet.